ABVC BioPharma, Inc. Debt Instrument, Fair Value Disclosure
ABVC BioPharma, Inc. (ABVC) had Debt Instrument, Fair Value Disclosure of $559.01 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-08-12
- 2026-06-30: Debt Instrument, Fair Value Disclosure $559.01K.
- 2026-03-31: Debt Instrument, Fair Value Disclosure $559.01K.
- 2025-12-31: Debt Instrument, Fair Value Disclosure $559.01K.
- 2025-06-30: Debt Instrument, Fair Value Disclosure $309.01K.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $559.01K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $559.01K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $559.01K 10-Q · filed 2026-08-12 |
| 2025-06-30 | $309.01K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.26M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $1.74M 10-Q/A · filed 2026-03-03 |
| 2023-12-31 | $2.41M 10-K · filed 2025-04-15 |
| 2023-02-23 | $3.70M 10-Q · filed 2023-11-15 |